Brighton Jones LLC’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16,923
| Closed | -$129K | – | 676 |
|
|
2024
Q2 | $129K | Hold |
16,923
| – | – | ﹤0.01% | 599 |
|
|
2024
Q1 | $152K | Buy |
+16,923
| New | +$152K | 0.01% | 593 |
|
|
2023
Q4 | – | Sell |
-16,925
| Closed | -$102K | – | 615 |
|
|
2023
Q3 | $102K | Hold |
16,925
| – | – | 0.01% | 523 |
|
|
2023
Q2 | $117K | Buy |
16,925
+153
| +0.9% | +$1.06K | 0.01% | 525 |
|
|
2023
Q1 | $263K | Buy |
16,772
+78
| +0.5% | +$1.23K | 0.02% | 409 |
|
|
2022
Q4 | $334K | Sell |
16,694
-9
| -0.1% | -$180 | 0.02% | 311 |
|
|
2022
Q3 | $298K | Buy |
16,703
+9
| +0.1% | +$161 | 0.02% | 334 |
|
|
2022
Q2 | $371K | Hold |
16,694
| – | – | 0.02% | 302 |
|
|
2022
Q1 | $464K | Hold |
16,694
| – | – | 0.02% | 290 |
|
|
2021
Q4 | $758K | Hold |
16,694
| – | – | 0.04% | 211 |
|
|
2021
Q3 | $1.39M | Buy |
16,694
+50
| +0.3% | +$4.17K | 0.07% | 125 |
|
|
2021
Q2 | $1.58M | Hold |
16,644
| – | – | 0.08% | 111 |
|
|
2021
Q1 | $2.77M | Buy |
+16,644
| New | +$2.77M | 0.16% | 62 |
|